Skip to main content
Log in

Robotic Treatment for Large Duodenal Gastrointestinal Stromal Tumor

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Duodenal gastrointestinal stromal tumors (D-GISTs) represent a rare entity.1 Surgery is the primary treatment choice for localized or potentially resectable D-GISTs. The main principle is the complete excision of the lesion with microscopically negative margins, without performing lymph node dissection.2 Nevertheless, the best surgical choice is still controversial since the strategy depends not only on the tumor size but also on its anatomic location.3,4 As a result, surgical management ranges from a major resection such as pancreaticoduodenectomy to more conservative procedures.5,6,7,8 This video presents a duodenal sparing robotic resection of a large GIST of the second-third duodenal portion.

Methods

A 49-year-old healthy female complained episodes of melena. Endoscopy with endoscopic ultrasound identified a 6-cm lesion of the second-third portion of the duodenum with recent bleeding, arising from muscolaris propria. A computed tomography scan confirmed a large mass suspected to be a GIST without metastases or involvement of the ampulla of Vater. On the basis of these findings, after a multidisciplinary consultation, she was offered robotic surgery with a radical intent.

Results

A duodenal-sparing da Vinci®Si™ resection with robot-sewn primary duodenal closure was performed. After an uneventful postoperative course, the patient was discharged on post-operative day 7. Final pathology revealed a high-grade risk D-GIST with free margins: adjuvant Imatinib was recommended.9 At 4 years follow-up, no recurrence has been detected.

Conclusions

A robotic approach might be considered in cases of large D-GISTs amenable to a conservative R0 surgery. This system provides several technical advantages that facilitate otherwise complex resection and reconstruction.10

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ma GL, Murphy JD, Martinez ME, Sicklick JK. Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based study. Cancer Epidemiol Biomarkers Prev. 2015;24(1):298–302.

    Article  Google Scholar 

  2. Network NCC (2019); Guidelines soft tissue sarcoma. https://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf. [Accessed February 4, 2019].

  3. Lee SY, Goh BK, Sadot E, et al. Surgical strategy and outcomes in duodenal gastrointestinal stromal tumor. Ann Surg Oncol. 2017;24(1):202–210.

    Article  Google Scholar 

  4. Lee SJ, Song KB, Lee YJ, et al. Clinicopathologic characteristics and optimal surgical treatment of duodenal gastrointestinal stromal tumor. J Gastrointest Surg. 2019;23(2):270–279.

    Article  CAS  Google Scholar 

  5. El-Gendi A, El-Gendi S, El-Gendi M. Feasibility and oncological outcomes of limited duodenal resection in patients with primary nonmetastatic duodenal GIST. J Gastrointest Surg. 2012;16(12):2197–2202.

    Article  Google Scholar 

  6. Chok AY, Koh YX, Ow MY, Allen JC, Jr., Goh BK. A systematic review and meta-analysis comparing pancreaticoduodenectomy versus limited resection for duodenal gastrointestinal stromal tumors. Ann Surg Oncol. 2014;21(11):3429–3438.

    Article  Google Scholar 

  7. Krishnamurthy G, Singh H, Sharma V, Savlania A, Vasishta RK. Therapeutic challenges in the management of bleeding duodenal gastrointestinal stromal tumor: a case report and review of literature. J. Gastrointest Cancer. 2019;50(1):170–174.

    Article  Google Scholar 

  8. Huang Y, Chen G, Lin L, et al. Resection of GIST in the duodenum and proximal jejunum: a retrospective analysis of outcomes. Eur. J. Surg. Oncol. 2019;45(10):1950–1956.

    Article  Google Scholar 

  9. Laurent M, Brahmi M, Dufresne A, et al. Adjuvant therapy with imatinib in gastrointestinal stromal tumors (GISTs)—review and perspectives. Transl Gastroenterol Hepatol. 2019;4:24.

    Article  Google Scholar 

  10. Downs-Canner S, Van Der Vliet WJ, Thoolen SJ, et al. Robotic surgery for benign duodenal tumors. J. Gastrointest. Surg. 2015;19(2):306–312.

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank Mrs Anna Racca for her significant contribution to revising the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Felice Borghi MD.

Ethics declarations

Disclosure

The authors declare that they have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

The video was awarded the Best Video Award at 12th International Gastric Cancer Congress (IGCC), Beijing, 20–23 April 2017. Supplementary material 1 (MP4 238519 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marano, A., Allisiardi, F., Perino, E. et al. Robotic Treatment for Large Duodenal Gastrointestinal Stromal Tumor. Ann Surg Oncol 27, 1101–1102 (2020). https://doi.org/10.1245/s10434-019-08041-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-019-08041-z

Navigation